Over the past four years, the dialysis industry has spent $233 million on both political offense and defense in California. Most of it went toward protecting its revenues against ballot initiatives, but the industry also strategically worked the corridors of the state Capitol.
COVID-19’s “long haulers” — patients with lingering effects of the disease — have joined the ranks of Americans with preexisting conditions. For those shopping for health coverage on the individual market, here’s help navigating an uncharted insurance landscape.
Californians are again being asked to weigh in on a dialysis ballot measure. This one purports to target patient safety, and dialysis industry giants are once again spending big to defeat it.
The progressive Change Now PAC launched a campaign ad, which also circulated on Facebook, criticizing President Donald Trump and Sen. Thom Tillis (R-N.C.) for not “fighting” for people with diabetes who struggle with the high cost of insulin.
Montana’s Matt Rosendale and many other Republican congressional candidates face the challenge of convincing voters they support safeguards on preexisting conditions even as they oppose the Affordable Care Act, which codifies those safeguards.
Since the COVID-19 pandemic hit, more patients are administering dialysis to themselves at home rather than receiving it in a clinic. Although home dialysis limits exposure to the virus, it comes with its own challenges.
Counting deaths caused by the coronavirus pandemic is easier said than done. Without widespread testing, officials must sort through presumed COVID deaths and those who died with infections rather than from them. Then there are the indirect deaths of people who died from circumstances created by the pandemic.
Democrats were not impressed with the Trump administration’s COVID-19 national testing strategy document submitted to Congress this week. They say the pandemic requires more direction from the federal government, while the administration wants to give nearly all the responsibility to the states. Meanwhile, in an effort to shore up his base of senior voters, President Donald Trump has unveiled a plan to limit what those on Medicare must pay out-of-pocket for insulin. Anna Edney of Bloomberg News, Erin Mershon of STAT News and Joanne Kenen of Politico join KHN’s Julie Rovner to discuss this and more. Also, Rovner interviews KHN’s Phil Galewitz, who wrote the latest KHN-NPR “Bill of the Month” installment about a patient who thought he might have COVID-19, did everything right and got a big bill, anyway.
Older adults are at serious risk during this pandemic and have been advised to avoid contact with others. Yet many still need essential services, and programs are scrambling to adapt.
Just 5 miles from Mar-a-Lago, the POTUS’ outpost, Florida residents find that the president’s pledge to make testing accessible hasn’t materialized.